August 24, 2004; 63 (4) Clinical/Scientific Notes
Melatonin, 3 mg, is effective for migraine prevention
M. F.P. Peres, E. Zukerman, F. da Cunha Tanuri, F. R. Moreira, J. Cipolla-Neto
First published August 23, 2004, DOI: https://doi.org/10.1212/01.WNL.0000134653.35587.24
M. F.P. Peres
MD PhD
E. Zukerman
MD
F. da Cunha Tanuri
MD
F. R. Moreira
BS
J. Cipolla-Neto
MD PhD
Melatonin, 3 mg, is effective for migraine prevention
M. F.P. Peres, E. Zukerman, F. da Cunha Tanuri, F. R. Moreira, J. Cipolla-Neto
Neurology Aug 2004, 63 (4) 757; DOI: 10.1212/01.WNL.0000134653.35587.24
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 63 no. 4 757
PubMed:
Print ISSN:
Online ISSN:
History:
- Received January 31, 2004
- Accepted April 14, 2004
- First Published August 23, 2004.
Copyright & Usage:
© 2004
Author Disclosures
- M. F.P. Peres, MD PhD,
- E. Zukerman, MD,
- F. da Cunha Tanuri, MD,
- F. R. Moreira, BS and
- J. Cipolla-Neto, MD PhD
- M. F.P. Peres, MD PhD,
- E. Zukerman, MD,
- F. da Cunha Tanuri, MD,
- F. R. Moreira, BS and
- J. Cipolla-Neto, MD PhD
- From the Hospital Israelita Albert Einstein (Drs. Peres, Zukerman, da Cunha Tanuri, and Moreira), São Paulo, Brazil; and Instituto de Ciências Biomédicas (Dr. Cipolla-Neto), Universidade de São Paulo, Brazil.
- Address correspondence and reprint requests to Dr. Mario F.P. Peres, Al. Joaquim Eugenio de Lima, 881 cj 708, 01403-001 São Paulo SP, Brazil; e-mail: marioperes{at}yahoo.com
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
Prophylaxis of menstrual migraine with triptansProblems and possibilitiesElizabeth Loder et al.Neurology, December 10, 2002 -
Articles
Medication-overuse headache in patients with cluster headacheK. Paemeleire, A. Bahra, S. Evers et al.Neurology, July 10, 2006 -
Brief Communications
A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraineLawrence C. Newman, Richard B. Lipton, Christine L. Lay et al.Neurology, July 01, 1998 -
Brief Communications
Cluster headache with auraStephen D. Silberstein, Rachel Niknam, Todd D. Rozen et al.Neurology, January 11, 2000